GeoVax Labs Inc at JPMorgan Healthcare Conference Transcript
And welcome to our last presentation for the day, GeoVax Labs from Smyrna, Georgia. GeoVax is focused on immuno-oncology vaccines. And presenting for the Company is their Chairman and CEO, David Dodd.
Thank you, Tony. First, [man], I mean I was thinking Tony La Russa. And I said, you've got a famous name there, but it's Tony Russo. Anyway, it isn't, I wish [were]. Anyway, thank you.
So if you have your phones onto the game, silence them. And if you're not aware that there's a game, University of Georgia is playing TCU. And we have some people here upset that we're here rather than in a bar watching their Bulldogs.
But anyway, thank you for being here. It's a pleasure to tell you about GeoVax. And again, I'll probably get through with this. And so, if you have questions outside, we can talk about them whatever, like to.
So indeed, we are a clinical-stage program. We're in Phase 2 clinical, we're developing both immunotherapies in oncology as well as
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |